Allogeneic lymphocyte therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic lymphocyte therapy, covering 2017-02-15 to 2017-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]